Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A, Breast, Cancer—Epidemiology. Risk factors, classification, prognostic markers, and current treatment Strategies—An updated review. Cancers. 2021;13:4287. https://doi.org/10.3390/cancers13174287.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rahman WT, Helvie MA. Breast cancer screening in average and high-risk women. Best Pract Res Clin Obstet Gynecol. 2022;83:3–14. https://doi.org/10.1016/j.bpobgyn.2021.11.007.

Article  Google Scholar 

Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. Cancer J Clin. 2007;57(1):43–66. https://doi.org/10.3322/canjclin.57.1.43.

Article  Google Scholar 

Standring S, editor. Gray’s Anatomy E-Book: Gray’s Anatomy E-Book. Elsevier Health Sciences; 2021, p. 22.

Zhu W, Nelson CM. Adipose and mammary epithelial tissue engineering. Biomatter. 2013;3(3):e24630. https://doi.org/10.4161/biom.24630.

Article  PubMed  PubMed Central  Google Scholar 

Javed A, Lteif A. Development of the human breast. In: Seminars in plastic surgery (Vol. 27, No. 01). Thieme Medical Publishers; 2013. pp. 005–012. https://doi.org/10.1055/s-0033-1343989.

Johnson MC, Cutler ML. Anatomy and physiology of the breast. In: Jatoi I, Rody A, editors. Management of breast diseases. Cham: Springer; 2016. https://doi.org/10.1007/978-3-319-46356-8_1.

Chapter  Google Scholar 

Al-Shami K, Awadi S, Alsheikh AM, Al-Sharif S, Ala’Bereshy R, Al-Eitan SF, Banikhaled SH, Al-Qudimat A, Al-Zoubi RM, Al Zoubi MS. Estrogens and the risk of breast cancer: a narrative review of literature. Heliyon. https://doi.org/10.1016/j.heliyon.2023.e20224.

Yue W, Wang JP, Li Y, Fan P, Liu G, Zhang N, Conaway M, Wang H, Korach KS, Bocchinfuso W, Santen R. Effects of estrogen on breast cancer development: role of estrogen receptor independent mechanisms. Int J Cancer. 2010;127(8):1748–57. https://doi.org/10.1002/ijc.25207.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhou Z, Qiao JX, Shetty A, et al. RETRACTED ARTICLE: regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. Cell Mol Life Sci. 2014;71:1549. https://doi.org/10.1007/s00018-013-1376-3.

Article  PubMed  CAS  Google Scholar 

Ercan C, van Diest PJ, Vooijs M. Mammary development and breast cancer: the role of stem cells. Curr Mol Med. 2011;11:270–85. https://doi.org/10.2174/156652411795678007.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Feng Y, et al. Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 2018;5(2):77–106. https://doi.org/10.1016/j.gendis.2018.05.001.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Giancotti FG. Mechanisms governing metastatic dormancy and reactivation. Cell 2013;155(4):750–764. https://doi.org/10.1016/j.cell.2013.10.029.

Alvarado M, Ozanne E, Esserman L. Overdiagnosis and overtreatment of breast cancer. American Society of Clinical Oncology. Educational Book. 2012;32(1):e40–5. https://doi.org/10.14694/EdBook_AM.2012.32.30.

Article  Google Scholar 

Hophan SL, Odnokoz O, Liu H, Luo Y, Khan S, Gradishar W, Zhou Z, Badve S, Torres MA. Yong Wan, Ductal carcinoma in situ of breast: From molecular etiology to therapeutic management. Endocrinology 2022;163(4):bqac027, https://doi.org/10.1210/endocr/bqac027.

Chen W, Guimei Wang, and, Zhang G. Insights into the transition of ductal carcinoma in situ to invasive ductal carcinoma: morphology, molecular portraits, and the tumor microenvironment. Cancer Biology Med. 2022;19:1487. https://doi.org/10.20892/j.issn.2095-3941.2022.0440.

Article  CAS  Google Scholar 

Piri L, Welcsh M-C, King. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Human Mol Genet. 2001;10(7):705–713, https://doi.org/10.1093/hmg/10.7.705.

Mylavarapu S, Das A, Roy M. Role of BRCA mutations in the modulation of response to platinum therapy. Front Oncol. 2018;8:16. https://doi.org/10.3389/fonc.2018.00016.

Article  PubMed  PubMed Central  Google Scholar 

Blondeaux E, Arecco L, Punie K, Graffeo R, Toss A, De Angelis C, Trevisan L, Buzzatti G, Linn SC, Dubsky P, Cruellas M. Germline TP53 pathogenic variants and breast cancer: a narrative review. Cancer Treat Rev. 2023;114:102522. https://doi.org/10.1016/j.ctrv.2023.102522.

Article  PubMed  CAS  Google Scholar 

Chubb D, Broderick P, Dobbins S, et al. Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer. Nat Commun. 2016;7:11883. https://doi.org/10.1038/ncomms11883.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ayal B, Gussow EV, Koonin N, Auslander. Identification of combinations of somatic mutations that predict cancer survival and immunotherapy benefit. NAR Cancer. 2021;3:zcab017. https://doi.org/10.1093/narcan/zcab017.

Article  Google Scholar 

Gasparyan M, Lo MC, Jiang H, Lin CC, Sun D. Combined p53-and PTEN-deficiency activates expression of mesenchyme homeobox 1 (MEOX1) required for growth of triple-negative breast cancer. J Biol Chem. 2020;295(34):12188–202. https://doi.org/10.1074/jbc.RA119.010710.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yuan T, Cantley L. PI3K pathway alterations in cancer: variations on a theme. Oncogene. 2008;27:5497–510. https://doi.org/10.1038/onc.2008.245.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Buocikova V, Rios-Mondragon I, Pilalis E, Chatziioannou A, Miklikova S, Mego M, Pajuste K, Rucins M, Yamani NE, Longhin EM, et al. Epigenetics in breast Cancer therapy—new strategies and future nanomedicine perspectives. Cancers. 2020;12:3622. https://doi.org/10.3390/cancers12123622.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kanwal R, Gupta S. Epigenetic modifications in cancer. Clin Genet. 2012;81(4):303–11. https://doi.org/10.1111/j.1399-0004.2011.01809.x.

Article  PubMed  CAS  Google Scholar 

McCabe MT, Brandes JC, Vertino PM. Cancer DNA methylation: molecular mechanisms and clinical implications. Clin Cancer Res. 2009;15(12):3927–37.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kulis M, Esteller M. DNA methylation and cancer. Adv Genet. 2010;70:27–56. https://doi.org/10.1200/JCO.2004.07.151.

Article  PubMed  CAS  Google Scholar 

Cheng Y, He C, Wang M, et al. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. Sig Transduct Target Ther. 2019;4:62. https://doi.org/10.1038/s41392-019-0095-0.

Article  Google Scholar 

Jacot W, Lopez-Crapez E, Mollevi C, Boissière-Michot F, Simony-Lafontaine J, Ho-Pun-Cheung A, Chartron E, Theillet C, Lemoine A, Saffroy R, et al. BRCA1 promoter hypermethylation is associated with good prognosis and chemosensitivity in triple-negative breast cancer. Cancers. 2020;12:828. https://doi.org/10.3390/cancers12040828.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ades F, Tryfonidis K, Zardavas D. The past and future of breast cancer treatment—from the papyrus to individualised treatment approaches. Ecancermedicalscience. 2017;11. https://doi.org/10.3332/ecancer.2017.746.

Mutebi M, Anderson BO, Duggan C, Adebamowo C, Agarwal G, Ali Z, Bird P. Breast cancer treatment: a phased approach to implementation. Cancer 126(S10):2365–78. https://doi.org/10.1002/cncr.32910.

Tilsed CM, Fisher SA, Nowak AK, Lake RA, Lesterhuis WJ. Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action. Front Oncol. 2022;12:960317. https://doi.org/10.3389/fonc.2022.960317.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Asaoka M, Gandhi S, Ishikawa T, Takabe K. Neoadjuvant chemotherapy for breast cancer: past, present, and future. Breast Cancer: Basic Clin Res. 2020;14. https://doi.org/10.1177/1178223420980377.

Gambardella V, Tarazona N, Cejalvo JM, Lombardi P, Huerta M, Roselló S, Fleitas T, Roda D, Cervantes A. Personalized medicine: recent progress in Cancer Therapy. Cancers. 2020;12:1009. https://doi.org/10.3390/cancers12041009.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rakha EA, Tse GM, Quinn CM. An update on the pathological classification of breast cancer. Histopathology. 2023;82(1):5–16. https://doi.org/10.1111/his.14786.

Article  PubMed  Google Scholar 

Jögi A, Vaapil M, Johansson M, Påhlman S. Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors. Ups J Med Sci. 2012;117(2):217–24.